One-Year Remission Rate of Chronic Headache Comparing Video and Face-to-Face Consultations by Neurologist: Randomized Controlled Trial

Svein Ivar Bekkelund, Kai Ivar Müller, Svein Ivar Bekkelund, Kai Ivar Müller

Abstract

Background: Chronic headache causing severe headache-related disability for those affected by the disease is under- or misdiagnosed in many cases and therefore requires easy access to a specialist for optimal health care management.

Objective: The goal of the research is to determine whether video consultations are noninferior to face-to-face consultations in treating chronic headache patients referred to a specialist in Northern Norway.

Methods: Patients included in the study were recruited from general practice referrals to a specialist at a neurological department in Northern Norway (Tromsø) and diagnosed according to the International Headache Society classification system. In a randomized controlled design, the 1-year remission rate of chronic headache (change from ≥15 to <15 headache days per month during the last 3 months), patient satisfaction with a specialist consultation, and need for follow-up consultations by general practitioners were compared between groups consulted by video and face-to-face in a post hoc analysis. Data were collected by interview (baseline) and questionnaire (follow-up).

Results: From a baseline cohort of 402 headache patients consecutively referred from general practice to a specialist over 2.5 years, 58.0% (233/402) were classified as chronic headache and included in this study. Response rates were 71.7% (86/120) in the video group and 67.3% (76/113) in the face-to-face group. One-year remission from chronic headache was achieved in 43.0% (37/86) in the video group and 39.5% (30/76) in the face-to-face group (P=.38). Patient satisfaction with consultations were 86.5% (32/37; video) and 93.3% (28/30; face-to-face; P=.25). A total of 30% (11/37) in the video group and 53% (16/30) in the face-to-face group consulted general practitioners during the follow-up period (P=.03), and median number of consultations was 1 (IQR 0-13) and 1.5 (IQR 0-15), respectively (P=.19).

Conclusions: One-year remission rate from chronic headache was about 40% regardless of consultation form. Likewise, patient satisfaction with consultation and need for follow-up visits in general practice post consultation was similar. Treating chronic headache patients by using video consultations is not inferior to face-to-face consultations and may be used in clinical neurological practice.

Trial registration: ClinicalTrials.gov NCT02270177; https://ichgcp.net/clinical-trials-registry/NCT02270177.

Keywords: RCT; chronic headache; consultation; digital consultation; eHealth; follow-up; randomized controlled trial; remission; telemedicine; treatment; video consultation.

Conflict of interest statement

Conflicts of Interest: None declared.

©Svein Ivar Bekkelund, Kai Ivar Müller. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 13.12.2021.

Figures

Figure 1
Figure 1
Flowchart of patients with chronic headache referred to neurologists from general practitioners for headache fulfilling the study inclusion criteria.

References

    1. Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010 May;30(5):599–609. doi: 10.1111/j.1468-2982.2009.01941.x.CHA1941
    1. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998 Feb 04;279(5):381–383. doi: 10.1001/jama.279.5.381.jbr71292
    1. Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–1470. doi: 10.1111/j.1526-4610.2012.02223.x.
    1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia. 2013 Jul;33(9):629–808. doi: 10.1177/0333102413485658.33/9/629
    1. Reuter U. GBD 2016: still no improvement in the burden of migraine. Lancet Neurol. 2018 Nov;17(11):929–930. doi: 10.1016/S1474-4422(18)30360-0. S1474-4422(18)30360-0
    1. GBD 2016 Headache Collaborators Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):954–976. doi: 10.1016/S1474-4422(18)30322-3. S1474-4422(18)30322-3
    1. Karimi L, Wijeratne T, Crewther SG, Evans AE, Ebaid D, Khalil H. The migraine-anxiety comorbidity among migraineurs: a systematic review. Front Neurol. 2020;11:613372. doi: 10.3389/fneur.2020.613372. doi: 10.3389/fneur.2020.613372.
    1. Scher AI, Buse DC, Fanning KM, Kelly AM, Franznick DA, Adams AM, Lipton RB. Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study. Neurology. 2017 Aug 01;89(5):461–468. doi: 10.1212/WNL.0000000000004177. WNL.0000000000004177
    1. Messali A, Sanderson JC, Blumenfeld AM, Goadsby PJ, Buse DC, Varon SF, Stokes M, Lipton RB. Direct and indirect costs of chronic and episodic migraine in the united states: a web-based survey. Headache. 2016 Feb;56(2):306–322. doi: 10.1111/head.12755.
    1. Von Korff M, Stewart WF, Simon DJ, Lipton RB. Migraine and reduced work performance: a population-based diary study. Neurology. 1998 Jun;50(6):1741–1745. doi: 10.1212/wnl.50.6.1741.
    1. Potter R, Probyn K, Bernstein C, Pincus T, Underwood M, Matharu M. Diagnostic and classification tools for chronic headache disorders: a systematic review. Cephalalgia. 2019 May;39(6):761–784. doi: 10.1177/0333102418806864.
    1. Cevoli S, D'Amico D, Martelletti P, Valguarnera F, Del Bene E, De Simone R, Sarchielli P, Narbone M, Testa L, Genco S, Bussone G, Cortelli P. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia. 2009 Dec;29(12):1285–1293. doi: 10.1111/j.1468-2982.2009.01874.x.CHA1874
    1. Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB. Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2016 May;56(5):821–834. doi: 10.1111/head.12774.
    1. Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for people with migraine in Europe: evidence from the Eurolight study. J Headache Pain. 2018 Feb 01;19(1):10. doi: 10.1186/s10194-018-0839-1. 10.1186/s10194-018-0839-1
    1. Ryvlin P, Skorobogatykh K, Negro A, Sanchez-De La Rosa R, Israel-Willner H, Sundal C, MacGregor EA, Guerrero AL. Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey. BMC Neurol. 2021 Jan 04;21(1):1. doi: 10.1186/s12883-020-02014-6. 10.1186/s12883-020-02014-6
    1. Tassorelli C, Farm I, Kettinen H, de la Torre ER, Stretenovic S, Thomas W, Vriezen P, Krause D, Craven A. Access to care—an unmet need in headache management? J Headache Pain. 2014;15:20. doi: 10.1186/1129-2377-15-20. 1129-2377-15-20
    1. Müller KI, Alstadhaug KB, Bekkelund SI. Acceptability, feasibility, and cost of telemedicine for nonacute headaches: a randomized study comparing video and traditional consultations. J Med Internet Res. 2016 May 30;18(5):e140. doi: 10.2196/jmir.5221. v18i5e140
    1. Eysenbach G, CONSORT-EHEALTH Group CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011 Dec 31;13(4):e126. doi: 10.2196/jmir.1923. v13i4e126
    1. Müller KI, Alstadhaug KB, Bekkelund SI. A randomized trial of telemedicine efficacy and safety for nonacute headaches. Neurology. 2017 Jul 11;89(2):153–162. doi: 10.1212/WNL.0000000000004085. WNL.0000000000004085
    1. Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine. Cephalalgia. 2011 Feb;31(3):357–367. doi: 10.1177/0333102410379890. 0333102410379890
    1. Lundqvist C, Benth JS, Grande RB, Aaseth K, Russell MB. A vertical VAS is a valid instrument for monitoring headache pain intensity. Cephalalgia. 2009 Oct;29(10):1034–1041. doi: 10.1111/j.1468-2982.2008.01833.x. CHA1833
    1. Devineni T, Blanchard EB. A randomized controlled trial of an internet-based treatment for chronic headache. Behav Res Ther. 2005 Mar;43(3):277–292. doi: 10.1016/j.brat.2004.01.008.S0005-7967(04)00065-8
    1. Friedman DI, Rajan B, Seidmann A. A randomized trial of telemedicine for migraine management. Cephalalgia. 2019 Oct;39(12):1577–1585. doi: 10.1177/0333102419868250.
    1. Wang S, Fuh J, Lu S, Juang K. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology. 2007 Feb 20;68(8):591–596. doi: 10.1212/01.wnl.0000252800.82704.62.01.wnl.0000252800.82704.62
    1. Hagen K, Kristoffersen ES, Winsvold BS, Stovner LJ, Zwart J. Remission of chronic headache: an 11-year follow-up study. Data from the Nord-Trøndelag Health Surveys 1995-1997 and 2006-2008. Cephalalgia. 2018 Dec;38(14):2026–2034. doi: 10.1177/0333102418769940.
    1. Wechsler LR. Advantages and limitations of teleneurology. JAMA Neurol. 2015 Mar;72(3):349–354. doi: 10.1001/jamaneurol.2014.3844.2089220
    1. Wilkinson JR, Spindler M, Wood SM, Marcus SC, Weintraub D, Morley JF, Stineman MG, Duda JE. High patient satisfaction with telehealth in Parkinson disease: a randomized controlled study. Neurol Clin Pract. 2016 Jun;6(3):241–251. doi: 10.1212/CPJ.0000000000000252. NEURCLINPRACT2015013185
    1. Chua R, Craig J, Esmonde T, Wootton R, Patterson V. Telemedicine for new neurological outpatients: putting a randomized controlled trial in the context of everyday practice. J Telemed Telecare. 2002;8(5):270–273. doi: 10.1177/1357633X0200800505.
    1. George BP, Scoglio NJ, Reminick JI, Rajan B, Beck CA, Seidmann A, Biglan KM, Dorsey ER. Telemedicine in leading US neurology departments. Neurohospitalist. 2012 Oct 17;2(4):123–128. doi: 10.1177/1941874412450716. 10.1177_1941874412450716
    1. Yurkiewicz IR, Lappan CM, Neely ET, Hesselbrock RR, Girard PD, Alphonso AL, Tsao JW. Outcomes from a US military neurology and traumatic brain injury telemedicine program. Neurology. 2012 Sep 18;79(12):1237–1243. doi: 10.1212/WNL.0b013e31826aac33.WNL.0b013e31826aac33
    1. Davis LE, Coleman J, Harnar J, King MK. Teleneurology: successful delivery of chronic neurologic care to 354 patients living remotely in a rural state. Telemed J E Health. 2014 May;20(5):473–477. doi: 10.1089/tmj.2013.0217.
    1. Davis LE, Harnar J, LaChey-Barbee LA, Pirio Richardson S, Fraser A, King MK. Using teleneurology to deliver chronic neurologic care to rural veterans: analysis of the first 1,100 patient visits. Telemed J E Health. 2019 Apr;25(4):274–278. doi: 10.1089/tmj.2018.0067.
    1. Kristoffersen ES, Sandset EC, Winsvold BS, Faiz KW, Storstein AM. Experiences of telemedicine in neurological out-patient clinics during the COVID-19 pandemic. Ann Clin Transl Neurol. 2021 Feb;8(2):440–447. doi: 10.1002/acn3.51293. doi: 10.1002/acn3.51293.
    1. Gunasekeran DV, Tseng RMWW, Tham Y, Wong TY. Applications of digital health for public health responses to COVID-19: a systematic scoping review of artificial intelligence, telehealth and related technologies. NPJ Digit Med. 2021 Feb 26;4(1):40. doi: 10.1038/s41746-021-00412-9. doi: 10.1038/s41746-021-00412-9.10.1038/s41746-021-00412-9
    1. Golinelli D, Boetto E, Carullo G, Nuzzolese AG, Landini MP, Fantini MP. Adoption of digital technologies in health care during the COVID-19 pandemic: systematic review of early scientific literature. J Med Internet Res. 2020 Nov 06;22(11):e22280. doi: 10.2196/22280. v22i11e22280
    1. Svendsen MT, Tiedemann SN, Andersen KE. Pros and cons of eHealth: a systematic review of the literature and observations in Denmark. SAGE Open Med. 2021;9:20503121211016179. doi: 10.1177/20503121211016179. 10.1177_20503121211016179
    1. Angus-Leppan H, Guiloff AE, Benson K, Guiloff RJ. Navigating migraine care through the COVID-19 pandemic: an update. J Neurol. 2021 May 17;:1–8. doi: 10.1007/s00415-021-10610-w. 10.1007/s00415-021-10610-w
    1. Hickey MD, Sergi F, Zhang K, Spinelli MA, Black D, Sola C, Blaz V, Nguyen JQ, Oskarsson J, Gandhi M, Havlir DV. Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV. J Telemed Telecare. 2020 Dec 20;:1357633X20976036. doi: 10.1177/1357633X20976036.
    1. Allida S, Du H, Xu X, Prichard R, Chang S, Hickman LD, Davidson PM, Inglis SC. mHealth education interventions in heart failure. Cochrane Database Syst Rev. 2020 Jul 02;7:CD011845. doi: 10.1002/14651858.CD011845.pub2.
    1. Alessi J, de Oliveira GB, Franco DW, Becker AS, Knijnik CP, Kobe GL, Amaral BB, de Brito A, Schaan BD, Telo GH. Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: a randomized controlled trial. Acta Diabetol. 2021 Jul;58(7):899–909. doi: 10.1007/s00592-021-01690-1.10.1007/s00592-021-01690-1
    1. Baek Y, Jeong K, Lee S, Kim H, Seo B, Jin H. Feasibility and effectiveness of assessing subhealth using a mobile health management app (MibyeongBogam) in early middle-aged koreans: randomized controlled trial. JMIR Mhealth Uhealth. 2021 Aug 19;9(8):e27455. doi: 10.2196/27455. v9i8e27455
    1. Binder EF, Christensen JC, Stevens-Lapsley J, Bartley J, Berry SD, Dobs AS, Fortinsky RH, Hildreth KL, Kiel DP, Kuchel GA, Marcus RL, McDonough CM, Orwig D, Sinacore DR, Schwartz RS, Volpi E, Magaziner J, Schechtman KB. A multi-center trial of exercise and testosterone therapy in women after hip fracture: design, methods and impact of the COVID-19 pandemic. Contemp Clin Trials. 2021 May;104:106356. doi: 10.1016/j.cct.2021.106356.S1551-7144(21)00092-6
    1. Kolcun JPG, Ryu WHA, Traynelis VC. Systematic review of telemedicine in spine surgery. J Neurosurg Spine. 2020 Oct 30;:1–10. doi: 10.3171/2020.6.SPINE20863.2020.6.SPINE20863
    1. Harkey K, Kaiser N, Zhao J, Hetherington T, Gutnik B, Matthews BD, Kelz RR, Reinke CE. Postdischarge virtual visits for low-risk surgeries: a randomized noninferiority clinical trial. JAMA Surg. 2021 Mar 01;156(3):221–228. doi: 10.1001/jamasurg.2020.6265.2775062
    1. Maguire R, McCann L, Kotronoulas G, Kearney N, Ream E, Armes J, Patiraki E, Furlong E, Fox P, Gaiger A, McCrone P, Berg G, Miaskowski C, Cardone A, Orr D, Flowerday A, Katsaragakis S, Darley A, Lubowitzki S, Harris J, Skene S, Miller M, Moore M, Lewis L, DeSouza N, Donnan PT. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) BMJ. 2021 Jul 21;374:n1647. doi: 10.1136/bmj.n1647.
    1. Ozen S, Senlikci HB, Guzel S, Yemisci OU. Computer game assisted task specific exercises in the treatment of motor and cognitive function and quality of life in stroke: a randomized control study. J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105991. doi: 10.1016/j.jstrokecerebrovasdis.2021.105991.S1052-3057(21)00396-7
    1. Rodriguez-Blanco C, Gonzalez-Gerez JJ, Bernal-Utrera C, Anarte-Lazo E, Perez-Ale M, Saavedra-Hernandez M. Short-term effects of a conditioning telerehabilitation program in confined patients affected by COVID-19 in the acute phase. a pilot randomized controlled trial. Medicina (Kaunas) 2021 Jul 03;57(7):1. doi: 10.3390/medicina57070684. medicina57070684
    1. Iversen MM, Igland J, Smith-Strøm H, Østbye T, Tell GS, Skeie S, Cooper JG, Peyrot M, Graue M. Effect of a telemedicine intervention for diabetes-related foot ulcers on health, well-being and quality of life: secondary outcomes from a cluster randomized controlled trial (DiaFOTo) BMC Endocr Disord. 2020 Oct 21;20(1):157. doi: 10.1186/s12902-020-00637-x. 10.1186/s12902-020-00637-x
    1. Buvik A, Bugge E, Knutsen G, Småbrekke A, Wilsgaard T. Patient satisfaction with remote orthopaedic consultation by using telemedicine: a randomised controlled trial. J Telemed Telecare. 2018 Jan 01;:1357633X18783921. doi: 10.1177/1357633X18783921.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться